<DOC>
	<DOCNO>NCT02090361</DOCNO>
	<brief_summary>In reconstructive surgery , loss cutaneous substance require use thin skin graft . This technique allow epidermization defect apply thin layer autologous epidermis . It reconstitute injured skin . Transplants cause retractile scar , adherent deep plan , may require revision surgery . Since decade , dermal matrix mainly use burn skin center . The collagen -elastin matrix advantage set operation skin graft contain elastic fiber , two asset improve result skin graft . Objective : Evaluation clinical efficacy addition dermal matrix skin graft Skin Foldability , day 360 . Methodology : This multicenter randomize study ( CHU Caen , Amiens , Rouen Lille ) Conduct study : The transplant perform accord protocol define inter -region surgeon . The implementation dermal matrix surgical technique thin skin graft ( group 1 ) thin skin graft perform alone ( group 2 ) time . Evaluation Criteria Main : Skin Foldability ( Uf ) assess graft site compare opposite side ungrafted evaluated Day 360 . Quantitative data measure cutometer Skin Elasticity Meter 580 ( Courage Khazaba Electronic GmbH ) . To achieve main objective , plan compare ratio Uf graft site opposite healthy site two group : skin + matrix graft , skin graft . Thus , Wilcoxon test independent sample use settle bilateral formulation null hypothesis ( difference two group ) alternative hypothesis ( difference two group ) . In determine overall risk first species 5 % power test detect 90 % expect alternative hypothesis difference main criterion evaluate least 59 patient group 118 patient total . Prospect If contribution dermal matrix loss skin substances improve skin pliability reduces pain , functional aesthetic sequela graft thin skin , dermal matrix may propose complementary treatment indication .</brief_summary>
	<brief_title>Efficacy Collagen-elastin Dermal Substitute Treatment Loss Cutaneous Substances With Skin Grafts</brief_title>
	<detailed_description />
	<criteria>Aged 18 Signed inform consent Patients loss cutaneous substance least 15 cm2 Patient Without bone exposure , vascular , joint tendon Eligibility surgical treatment skin graft Loss substance trauma ( avulsion , burn ) surgery ( skin excision ) Patient chronic wound Wound superinfect Patient unable local general skin graft Patient old recent skin injury strictly contralateral graft site . Patient unable consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>collagen -elastin matrix</keyword>
	<keyword>skin graft</keyword>
	<keyword>loss cutaneous substance</keyword>
</DOC>